More about Ibudilast
Posted: Mon Nov 06, 2017 11:00 am
More about Ibudilast, this time from Neurology Today:
Source: http://journals.lww.com/neurotodayonlin ... ?PostID=24
[...] Researchers reported that brain atrophy measured by the difference in the slope of brain parenchymal fraction was decreased by 48 percent among patients treated with ibudilast — a reduction of 0.00105 among patients on the drug — compared with a reduction of 0.00202 among those on placebo from baseline to week 96.
Source: http://journals.lww.com/neurotodayonlin ... ?PostID=24
[...] Researchers reported that brain atrophy measured by the difference in the slope of brain parenchymal fraction was decreased by 48 percent among patients treated with ibudilast — a reduction of 0.00105 among patients on the drug — compared with a reduction of 0.00202 among those on placebo from baseline to week 96.